Bao-tian Huang
No. 7 Raoping Road
Shantou, China
Shantou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Clinical-radiomic model development for local recurrence prediction in stereotactic body radiation therapy-treated lung cancer: comparative analysis with radiobiological models.
Journal: Scientific reports
Published: November 18, 2025
Machine learning-based prognostic model for local control prediction in lung cancer patients undergoing stereotactic body radiation therapy: a preliminary study.
Journal: European journal of medical research
Published: July 01, 2025
Development and validation of a nomogram for local control prediction in lung cancer patients treated with stereotactic body radiation therapy based on clinical, dosimetric, and inflammation-related parameters.
Journal: BMC pulmonary medicine
Published: July 24, 2024
External validation of radiobiological models for local control prediction in lung cancer patients treated with stereotactic body radiation therapy.
Journal: Frontiers in oncology
Published: May 11, 2024
Incorporating the inflammation-related parameters enhances the performance of the nomogram for predicting local control in lung cancer patients treated with stereotactic body radiation therapy.
Journal: Journal of cancer research and clinical oncology
Published: December 02, 2023
Developing a clinical-radiomic prediction model for 3-year cancer-specific survival in lung cancer patients treated with stereotactic body radiation therapy.
Journal: Journal of cancer research and clinical oncology
Published: October 07, 2023
Developing a Prediction Model for Radiation Pneumonitis in Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy Combined With Clinical, Dosimetric Factors, and Laboratory Biomarkers.
Journal: Clinical lung cancer
Published: March 16, 2023
The Clinical Outcomes, Prognostic Factors and Nomogram Models for Primary Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Journal: Frontiers in oncology
Published: January 27, 2022
A Combined Model to Improve the Prediction of Local Control for Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy Based on Radiomic Signature Plus Clinical and Dosimetric Parameters.
Journal: Frontiers in oncology
Published: November 20, 2021
Calculating the individualized fraction regime in stereotactic body radiotherapy for non-small cell lung cancer based on uncomplicated tumor control probability function.
Journal: Radiation oncology (London, England)
Published: January 10, 2019
Last Updated: 09/26/2026